Favorable prognosis of breast cancer brain metastases patients with limited intracranial and extracranial metastatic lesions

被引：2

作者：

Shi, Wei ^{[1
,2
,3
]}

Li, Yang ^{[4
]}

Sun, Hua ^{[1
,2
,3
]}

Zhang, Li ^{[1
,2
,3
]}

Meng, Jin ^{[1
,2
,3
]}

Wang, Xiaofang ^{[1
,2
,3
]}

Chen, Xingxing ^{[1
,2
,3
]}

Zhang, Xiaomeng ^{[1
,2
,3
]}

Mei, Xin ^{[1
,2
,3
]}

Ma, Jinli ^{[1
,2
,3
]}

Mo, Miao ^{[5
,6
]}

Zhou, Changming ^{[5
,6
]}

Liang, Fei ^{[7
]}

Shao, Zhimin ^{[8
]}

Zhang, Zhen ^{[1
,2
,3
]}

Guo, Xiaomao ^{[1
,2
,3
]}

Yu, Xiaoli ^{[1
,2
,3
]}

Yang, Zhaozhi ^{[1
,2
,3
]}

机构：

[1] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, 270 Dong An Rd, Shanghai 200032, Peoples R China

[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China

[3] Shanghai Clin Res Ctr Radiat Oncol, Shanghai Key Lab Radiat Oncol, Shanghai 200032, Peoples R China

[4] Jining Med Univ, Affiliated Hosp, Jining 272029, Shandong, Peoples R China

[5] Fudan Univ Shanghai, Canc Ctr, Dept Canc Prevent, Shanghai 200032, Peoples R China

[6] Fudan Univ Shanghai, Clin Stat Ctr, Canc Ctr, Shanghai 200032, Peoples R China

[7] Fudan Univ, Zhongshan Hosp, Dept Biostat, Shanghai, Peoples R China

[8] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200032, Peoples R China

来源：

RADIATION ONCOLOGY | 2023年 / 18卷 / 01期

基金：

中国国家自然科学基金;

关键词：

Brain metastases; Breast cancer; Oligometastases; Systemic therapy; Salvage local therapy; STEREOTACTIC RADIOSURGERY; OLIGOMETASTATIC DISEASE; RADIOTHERAPY; CAPECITABINE; MULTICENTER; ONCOLOGY; SURVIVAL; THERAPY; TRASTUZUMAB; LAPATINIB;

D O I：

10.1186/s13014-023-02293-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

BackgroundBreast cancer brain metastases (BCBM) are highly heterogenous with widely differing survival. The prognosis of the oligometastatic breast cancer (BC) patients with brain metastases (BM) has not been well studied. We aimed to investigate the prognosis of BCBM patients with limited intracranial and extracranial metastatic lesions.MethodsFour hundred and forty-five BCBM patients treated between 1st January 2008 and 31st December 2018 at our institute were included. Clinical characteristics and treatment information were obtained from patient's medical records. The updated breast Graded Prognostic Assessment (Breast GPA) was calculated.ResultsThe median OS after diagnosis of BM were 15.9 months. Median OS for patients with GPA 0-1.0, 1.5-2, 2.5-3 and 3.5-4 were 6.9, 14.2, 21.8, 42.6 months respectively. The total number of intracranial and extracranial metastatic lesions, in addition to the Breast GPA, salvage local therapy and systemic therapy (anti-HER2 therapy, chemotherapy and endocrine therapy) were demonstrated to be associated with prognosis. One hundred and thirteen patients (25.4%) had 1-5 total metastatic lesions at BM diagnosis. Patients with 1-5 total metastatic lesions had a significantly longer median OS of 24.3 months compared to those with greater than 5 total metastatic lesions with a median OS of 12.2 months (P < 0.001; multivariate HR 0.55, 95% CI, 0.43-0.72). Among the patients with 1-5 metastatic lesions, median OS for GPA 0-1.0 was 9.8 months, compared to 22.8, 28.8 and 71.0 for GPA 1.5-2.0, 2.5-3.0 and 3.5-4.0 respectively, which is much longer than the corresponding patients with greater than 5 total metastatic lesions, with medium OS of 6.8, 11.6, 18.6 and 42.6 months respectively for GPA 0-1.0, 1.5-2.0, 2.5-3.0 and 3.5-4.0.ConclusionsThe patients with 1-5 total metastatic lesions demonstrated better OS. The prognostic value of the Breast GPA and the survival benefit of salvage local therapy and continuation of systemic therapy after BM were confirmed.

引用

页数：12

共 40 条

[1]

Bartsch R., 2022, ESMO BC 2022

[2] Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases [J].

Bergen, Elisabeth S. ;

Berghoff, Anna S. ;

Medjedovic, Mela ;

Rudas, Margaretha ;

Fitzal, Florian ;

Bago-Horvath, Zsuzsanna ;

Dieckmann, Karin ;

Mader, Robert M. ;

Exner, Ruth ;

Gnant, Michael ;

Zielinski, Christoph C. ;

Steger, Guenther G. ;

Preusser, Matthias ;

Bartsch, Rupert .

CLINICAL CANCER RESEARCH, 2019, 25 (09) :2737-2744

[3] Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial [J].

Chang, Eric L. ;

Wefel, Jeffrey S. ;

Hess, Kenneth R. ;

Allen, Pamela K. ;

Lang, Frederick F. ;

Kornguth, David G. ;

Arbuckle, Rebecca B. ;

Swint, J. Michael ;

Shiu, Almon S. ;

Maor, Moshe H. ;

Meyers, Christina A. .

LANCET ONCOLOGY, 2009, 10 (11) :1037-1044

[4] Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients [J].

Chargari, Cyrus ;

Kirova, Youlia M. ;

Dieras, Veronique ;

Pena, Pablo Castro ;

Campana, Francois ;

Cottu, Paul H. ;

Pierga, JeanYves ;

Fourquet, Alain .

JOURNAL OF NEURO-ONCOLOGY, 2009, 93 (03) :379-384

[5]

Chmura SJ, 2022, J CLIN ONCOL, V40

[6]

/ClinicalTrials.gov, TRIAL SUP STER BOD R

[7]

ClinicalTrials.gov, RAD EXTR OL BREAST C

[8] Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer [J].

Cortes, J. ;

Kim, S. -B ;

Chung, W. -P ;

Im, S. -A ;

Park, Y. H. ;

Hegg, R. ;

Kim, M. H. ;

Tseng, L. -M ;

Petry, V ;

Chung, C. -F ;

Iwata, H. ;

Hamilton, E. ;

Curigliano, G. ;

Xu, B. ;

Huang, C. -S ;

Kim, J. H. ;

Chiu, J. W. Y. ;

Pedrini, J. L. ;

Lee, C. ;

Liu, Y. ;

Cathcart, J. ;

Bako, E. ;

Verma, S. ;

Hurvitz, S. A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (12) :1143-1154

[9] Capecitabine therapy of central nervous system metastases from breast cancer [J].

Ekenel, Meltem ;

Hormigo, Adilia M. ;

Peak, Scott ;

DeAngelis, Lisa M. ;

Abrey, Lauren E. .

JOURNAL OF NEURO-ONCOLOGY, 2007, 85 (02) :223-227

[10] Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials [J].

Gaspar, L ;

Scott, C ;

Rotman, M ;

Asbell, S ;

Phillips, T ;

Wasserman, T ;

McKenna, WG ;

Byhardt, R .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (04) :745-751

← 1 2 3 4 →